UroGen Pharma (URGN) Short Interest Ratio & Short Volume

$13.22
+0.01 (+0.08%)
(As of 05/17/2024 08:54 PM ET)

UroGen Pharma Short Interest Data

Current Short Volume
4,430,000 shares
Previous Short Volume
4,200,000 shares
Change Vs. Previous Month
+5.48%
Dollar Volume Sold Short
$61.22 million
Short Interest Ratio / Days to Cover
12.7
Last Record Date
April 30, 2024
Outstanding Shares
23,454,000 shares
Percentage of Shares Shorted
18.89%
Today's Trading Volume
232,100 shares
Average Trading Volume
330,352 shares
Today's Volume Vs. Average
70%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling UroGen Pharma ?

Sign up to receive the latest short interest report for UroGen Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

URGN Short Interest Over Time

URGN Days to Cover Over Time

URGN Percentage of Float Shorted Over Time

UroGen Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20244,430,000 shares $61.22 million +5.5%N/A12.7 $13.82
4/15/20244,200,000 shares $63.42 million +0.2%N/A11.5 $15.10
3/31/20244,190,000 shares $62.85 million -1.4%N/A12.6 $15.00
3/15/20244,250,000 shares $61.46 million +8.1%N/A12.4 $14.46
2/29/20243,930,000 shares $72.04 million -2.0%N/A12.7 $18.33
2/15/20244,010,000 shares $75.39 million +23.0%N/A13.2 $18.80
1/31/20243,260,000 shares $51.18 million -3.8%N/A11 $15.70
1/15/20243,390,000 shares $49.46 million -4.5%N/A12.9 $14.59
12/31/20233,550,000 shares $53.25 million +15.6%N/A13.5 $15.00
12/15/20233,070,000 shares $46.05 million +5.1%N/A11.3 $15.00
11/30/20232,920,000 shares $38.51 million +3.2%N/A12.4 $13.19
11/15/20232,830,000 shares $32.77 million +23.6%N/A11.4 $11.58
10/31/20232,290,000 shares $25.67 million +39.6%N/A7.9 $11.21
10/15/20231,640,000 shares $21.48 million +14.7%N/A2.6 $13.10
9/30/20231,430,000 shares $20.03 million +10.9%N/A2.3 $14.01
9/15/20231,290,000 shares $20.52 million -8.5%N/A2.1 $15.91
8/31/20231,410,000 shares $24.65 million -15.1%N/A2.2 $17.48
8/15/20231,660,000 shares $37.12 million +5.7%N/A2.7 $22.36
7/31/20231,570,000 shares $34.01 million +55.5%N/A2.8 $21.66
7/15/20231,010,000 shares $9.28 million +11.1%5.1%4 $9.19
6/30/2023909,100 shares $9.41 million +38.5%4.6%3.8 $10.35
6/15/2023656,300 shares $8.07 million -23.0%3.3%2.7 $12.29
5/31/2023852,100 shares $8.44 million -9.8%4.3%4.6 $9.90
5/15/2023944,700 shares $11.16 million +29.3%4.8%5.4 $11.81
4/30/2023730,500 shares $8.47 million -1.8%3.7%4.3 $11.59
4/15/2023743,700 shares $7.16 million +16.3%3.8%5.8 $9.63
3/31/2023639,500 shares $5.91 million +2.3%3.3%5.6 $9.24
3/15/2023625,300 shares $6.02 million +5.5%3.3%6.3 $9.63
2/28/2023592,900 shares $6.11 million +2.8%3.1%6.7 $10.30
2/15/2023576,700 shares $5.29 million +1.2%3.0%6.4 $9.17
1/31/2023569,700 shares $5.92 million +0.0%3.0%6.6 $10.39
1/15/2023569,600 shares $4.88 million -15.2%2.9%7.7 $8.56
12/30/2022671,700 shares $5.96 million -0.2%3.5%8.9 $8.87
12/15/2022673,000 shares $5.32 million +0.1%3.5%10.2 $7.91
11/30/2022672,600 shares $5.76 million -1.0%3.5%10.3 $8.57
11/15/2022679,700 shares $6.17 million -9.5%3.5%10.5 $9.08
10/31/2022751,100 shares $8.90 million -31.7%3.9%13 $11.85
10/15/20221,100,000 shares $12.65 million -20.3%5.8%19.5 $11.50
9/30/20221,380,000 shares $11.48 million -3.5%7.2%25.6 $8.32
9/15/20221,430,000 shares $13.46 million +1.4%7.5%15 $9.41
He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)

For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.

Click for his six specific AI stock in the crosshairs

URGN Short Interest - Frequently Asked Questions

What is UroGen Pharma's current short interest?

Short interest is the volume of UroGen Pharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 4,430,000 shares of URGN short. Learn More on UroGen Pharma's current short interest.

What is a good short interest ratio for UroGen Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. URGN shares currently have a short interest ratio of 13.0. Learn More on UroGen Pharma's short interest ratio.

Is UroGen Pharma's short interest increasing or decreasing?

UroGen Pharma saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 4,430,000 shares, an increase of 5.5% from the previous total of 4,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does UroGen Pharma's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to UroGen Pharma: Vanda Pharmaceuticals Inc. (4.17%), XOMA Co. (2.33%), 23andMe Holding Co. (12.81%), Nature's Sunshine Products, Inc. (0.50%), Ventyx Biosciences, Inc. (14.79%), CorMedix Inc. (17.94%), Rani Therapeutics Holdings, Inc. (10.88%), Aquestive Therapeutics, Inc. (5.79%), Mersana Therapeutics, Inc. (8.92%), Atai Life Sciences (5.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short UroGen Pharma stock?

Short selling URGN is an investing strategy that aims to generate trading profit from UroGen Pharma as its price is falling. URGN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against UroGen Pharma?

A short squeeze for UroGen Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of URGN, which in turn drives the price of the stock up even further.

How often is UroGen Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including URGN, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:URGN) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners